QuadMedicine

쿼드메디슨 · 464490

Health Care Pharmaceuticals · KOSDAQ

Small-cap

Market cap US$70M (₩96.6B)

Overview

QuadMedicine develops microneedle patches, tiny needle arrays embedded in a dissolvable tip that push drugs through the skin without a conventional injection, improving how reliably patients take their medicine.

It targets pharmaceutical companies and other drug developers who commission it to adapt already-approved drugs into this skin-delivery format. Listed on KOSDAQ, Korea's tech and small-cap board, the company operates as a contract development and manufacturing partner, earning milestone fees as client projects advance through research, prototype, and clinical stages.

Summary is AI-generated and may contain errors · figures from DART filings

Financials

Source: DART · FY ending Dec · latest FY2025

Revenue · FY2025

US$7.8M

▲ +15.0% YoY

Operating profit · FY2025

−US$4.6M

Loss widened

Net income · FY2025

−US$5M

Loss widened

Revenue, operating profit and net income by fiscal year (USD; KRW in parentheses).
Metric	FY2024	FY2025
Revenue	US$6.7M(₩9.3B)	US$7.8M(₩10.7B)
Operating profit	−US$3.2M(−₩4.4B)	−US$4.6M(−₩6.4B)
Net income	−US$3.6M(−₩5B)	−US$5M(−₩6.9B)

Revenue

FY2024US$6.7M
FY2025US$7.8M

Operating profit

FY2024−US$3.2M
FY2025−US$4.6M

Net income

FY2024−US$3.6M
FY2025−US$5M

Key ratios (FY2025)

ROE

-22.5%

Debt/Eq

66.2%

Op. margin

-59.7%

Net margin

-64.8%

Rev. YoY

▲ +15.0%

Price charts coming soon

Interactive price history isn't here yet. Would you use it?